ChemSpider 2D Image | (1R,3R,7E,17beta)-17-[(2R,3E,5S)-6-Hydroxy-5-methyl-6-(~2~H_3_)methyl(7,7,7-~2~H_3_)-3-hepten-2-yl]-9,10-secoestra-5,7-diene-1,3-diol | C27H38D6O3

(1R,3R,7E,17β)-17-[(2R,3E,5S)-6-Hydroxy-5-methyl-6-(2H3)methyl(7,7,7-2H3)-3-hepten-2-yl]-9,10-secoestra-5,7-diene-1,3-diol

  • Molecular FormulaC27H38D6O3
  • Average mass422.673 Da
  • Monoisotopic mass422.366699 Da
  • ChemSpider ID28637820

  • Double-bond stereo - Double-bond stereo

    defined stereocentres - 7 of 7 defined stereocentres

    Non-standard isotope - Non-standard isotope

More details:

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

(1R,3R,7E,17β)-17-[(2R,3E,5S)-6-Hydroxy-5-methyl-6-(2H3)methyl(7,7,7-2H3)-3-hepten-2-yl]-9,10-secoestra-5,7-dien-1,3-diol [German] [ACD/IUPAC Name]
(1R,3R,7E,17β)-17-[(2R,3E,5S)-6-Hydroxy-5-methyl-6-(2H3)methyl(7,7,7-2H3)-3-hepten-2-yl]-9,10-secoestra-5,7-diene-1,3-diol [ACD/IUPAC Name]
(1R,3R,7E,17β)-17-[(2R,3E,5S)-6-Hydroxy-5-méthyl-6-(2H3)méthyl(7,7,7-2H3)-3-heptén-2-yl]-9,10-sécoestra-5,7-diène-1,3-diol [French] [ACD/IUPAC Name]
1,3-Cyclohexanediol, 5-[(2E)-2-[(1R,3aS,7aR)-octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4-dimethyl-5-(methyl-d3)-2-hexen-1-yl-6,6,6-d3]-7a-methyl-4H-inden-4-ylidene]ethylidene]-, (1R,3R)- [ACD/Index Name]
(1R,3R)-5-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(E,2R,5S)-7,7,7-trideuterio-6-hydroxy-5-methyl-6-(trideuteriomethyl)hept-3-en-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]cyclohexane-1,3-diol
131918-61-1 [RN]
2070009-67-3 [RN]
MFCD08067734
Paricalcitol [USAN] [Wiki]
paricalcitol labeled d6
More...
  • Experimental Physico-chemical Properties
  • Miscellaneous

    • Bio Activity:

      Paricalcitol-D6 is the deuterated form of Paricalcitol(Zemplar), which is a drug used for the prevention and treatment of secondary hyperparathyroidism (excessive secretion of parathyroid hormone) associated with chronic renal failure. MedChem Express HY-76585
      Paricalcitol-D6 is the deuterated form of Paricalcitol(Zemplar), which is a drug used for the prevention and treatment of secondary hyperparathyroidism (excessive secretion of parathyroid hormone) associated with chronic renal failure. ;IC50 value:;Target: Vd analogChemically, it is 19-nor-1,25-(OH)2-vitamin D2 or 19-nor-1,25-dihydroxyvitamin D2, being an analog of 1,25-dihydroxyergocalciferol, the active form of vitamin D2. MedChem Express HY-76585
      VD/VDR MedChem Express HY-76585
      Vitamin D Related MedChem Express HY-76585
      Vitamin D Related; MedChem Express HY-76585

Predicted data is generated using the ACD/Labs Percepta Platform - PhysChem Module, version: 14.00

Density: 1.1±0.1 g/cm3
Boiling Point: 564.8±50.0 °C at 760 mmHg
Vapour Pressure: 0.0±3.5 mmHg at 25°C
Enthalpy of Vaporization: 97.5±6.0 kJ/mol
Flash Point: 238.3±24.7 °C
Index of Refraction: 1.609
Molar Refractivity: 128.6±0.3 cm3
#H bond acceptors: 3
#H bond donors: 3
#Freely Rotating Bonds: 5
#Rule of 5 Violations: 1
ACD/LogP: 5.83
ACD/LogD (pH 5.5): 5.35
ACD/BCF (pH 5.5): 6842.96
ACD/KOC (pH 5.5): 19357.91
ACD/LogD (pH 7.4): 5.35
ACD/BCF (pH 7.4): 6842.96
ACD/KOC (pH 7.4): 19357.91
Polar Surface Area: 61 Å2
Polarizability: 51.0±0.5 10-24cm3
Surface Tension: 54.7±3.0 dyne/cm
Molar Volume: 371.4±3.0 cm3

Click to predict properties on the Chemicalize site


Advertisement